Showing results (1-10 of 118) with videos related to
Sort By:
Pageof 12
The Cochrane Database of Systematic Reviews|July 23, 2008
Regular treatment with salmeterol for chronic asthma: serious adverse eventsChristopher J Cates, Matthew J CatesThe Cochrane Database of Systematic Reviews|April 20, 2012
Regular treatment with formoterol for chronic asthma: serious adverse eventsChristopher J Cates, Matthew J CatesThe Cochrane Database of Systematic Reviews|October 10, 2008
Regular treatment with formoterol for chronic asthma: serious adverse eventsChristopher J Cates, Matthew J Cates, Toby J LassersonBMC Medical Research Methodology|February 28, 2002
Simpson's paradox and calculation of number needed to treat from meta-analysisChristopher J CatesBMJ (Clinical Research Ed.)|March 24, 1990
A handout about tetanus immunisation: influence on immunisation rate in general practiceC J CatesThe Cochrane Database of Systematic Reviews|April 20, 2012
Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary diseaseCharlotta Karner, Christopher J CatesThe Cochrane Database of Systematic Reviews|March 18, 2011
Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary diseaseCharlotta Karner, Christopher J CatesThe Cochrane Database of Systematic Reviews|May 2, 2013
Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and childrenChristopher J Cates, Charlotta KarnerThe Cochrane Database of Systematic Reviews|September 9, 2011
The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary diseaseCharlotta Karner, Christopher J CatesThe Cochrane Database of Systematic Reviews|October 13, 2009
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse eventsChristopher J Cates, Toby J LassersonPageof 12